Neil Kao, M.D.

This is a list of interesting articles I have read on the internet, from a variety of sources, that help you see the larger, important facts and issues concerning COVID-19. There is a lot noise, controversy and fatigue about COVID-19. This list will be updated as I encounter relevant articles.

231002 COVID Map Shows 9 States Where Cases Are Rising This Month (msn.com) regions 7 & 8 = central US

231002 Warning that swine flu could return this winter: Experts urge millions of Brits to get jabs before season kicks off

231003 Latest COVID-19 studies show need for repeat rapid testing, targeting of antiviral prescriptions | ACP Internist Weekly | ACP Internist peak day 4 for omicron, vs. day 2 for flu A.hive antiviral if immunocompromised, age not so much a factor.

231003 FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | FDA

231003 FDA signs off on Novavax COVID vaccine. Here’s how it’s different from other shots

231004 Moderna combo COVID-19/flu vaccine effective in early-stage trial

231004 US Survey: About 7% of Adults, 1% of Children Have Had Long COVID ever or total, but at present time goes down to ~35%, so there’s some recovery

231005 Do I need the new COVID booster? Eligibility, side effects, cost and more

231005 First on ABC: 4M Americans have gotten latest COVID shot — on par with last fall’s vaccine rollout

231006 New COVID-19 Hospitalizations Decline for 3rd Straight Week

231007 Feeling Terrible After Your Covid Shot? Then It’s Probably Working

231008 New COVID shots still hard to find for some Americans

231008 COVID hospitalizations are still a ‘public health threat’ for America’s older adults, says CDC

231010 Frustration grows amid struggle to roll out new RSV, COVID shots for children

231010 CDC Coronavirus Treatment guidelines  see what’s new tab!

231012 ‘Waiting with bated breath’: Health clinics anxious for Covid vaccines weeks after rollout

231012 The COVID guide: Everything to know about the current state of variants, masking, vaccines and more

231013 HHS and Pfizer Reach Agreement to Increase Patient Access to Paxlovid plan

231013 Flu and RSV starting to tick up nationwide trends article

231015 EU delays approval of Novavax’s revised COVID vaccine FDA and EMA not always in sync

231016 A new possible explanation for long COVID could lead to a simple treatment for some patients

231017 New pill helps COVID smell and taste loss fade quickly only approved in Japan teasing

231017 Scientists finally know why people get more colds and flu in winter temperature is bad for immune system and okay for viruses, so use scarf!

231018 COVID-19 Hospitalizations Up Among Older Adults 63% from 1-8/23

231018 Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months

231018 Guillain-Barré syndrome risk greater after COVID-19 study indicates, during 6 weeks after infection, lower if vaccinated (not higher)

231018 Pfizer more than doubles price of lifesaving Covid-19 medication Paxlovid as US transitions out of pandemic phase $1,390 from $530 x 2.6x, vaccines $115-130/dose 4x “price gouging”

231019 COVID-19 Vaccination Willingness and Reasons for Vaccine Refusal 4 reasons

231023 COVID Is Ramping Up for a Year of Deadly Surges speculation about immunity types

231023 Despite promises, the new COVID vaccine booster appears harder to find. Here’s why business between wholesalers, pharmacies do not to overorder stock, insurances slow to pay

231023 COVID Vax During Pregnancy Linked to Lower Risk of Poor Neonatal Outcomes very good news during all 3 trimesters of pregnancy

231024 Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccine progress

231024 Next season, you may be able to take your flu vaccine at home AZ is hopeful FDA decision during Q1 2024, so be available for fall

231026 2% of kids and 7% of adults have gotten the new COVID shots, US data show “abysmal” hoping for 40% adults

261026 Getting flu and COVID shot together still reasonable amid safety review of potential stroke risk: Experts unreviewed FDA study, could be age, need more analysis

231026 What Is HV.1? Experts Explain the Latest COVID Variant

231026 Many businesses promote unproven long-COVID treatments, researchers say such as stem cell treatments or exosome therapies $11,900

231027 COVID-19 treatments to enter the market with a hefty price tag Paxlovid $1,390

231028 CDC Reveals Shockingly Few People Have Got New COVID Shot 10/14 7% adults, 2% children ~20% of >75 y/o

231029 Vitamin C for Patients With COVID-19 :More Evidence of Lack of Efficacy in Patients With Sepsis editorial

231029 A new Covid variant has become dominant amid slow uptake of the updated shots HV.1 > EG.5, versions of omicron. Just 3.5% total population vaccinated

231029 Vaccines against COVID-19, the seasonal flu and RSV are our best chance of preventing a winter surge symptoms, timing, shots simultaneously

231030 Biden administration looks to avoid vaccine hiccups as COVID-19 treatment coverage goes commercial can order Paxlovid from government until 12/15/23 or supply runs out. MC, MD free until 12/31/24. Uninsured free until 2028 who’s that?231030 Pfizer RSV vaccine lags GSK’s as head-to-head competition underway GSK ~66%, exclusive with CVS #1 pharmacy in US, others stock both $280/shot